Single radiologist with AI support versus two radiologists for screening mammograms

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Asymptomatic women aged 45–69 in the regional breast cancer screening program are randomized by day to have mammograms read either with an AI-assisted first reader (iCAD version 3) followed by a standard second radiologist read, or by the standard independent double reading without AI. The AI arm records the AI-assisted first read before the mandatory human second read to maintain legal double-reading requirements. Randomization assigns specific days to AI or non-AI reading to balance weekday workflow and case mix. The trial compares diagnostic outcomes such as cancer detection rate, recall rate, false positives, and workflow metrics between the two approaches.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* age 45-69, asymptomatic woman participating in breast cancer screening programme

Exclusion Criteria:

* clinical signs of breast disease - indication for diagnostic mammography

Where it's running

• University Hospital Olomouc
  Olomouc, Czechia Recruiting

Study contacts

• Study coordinator: Lucia Veverkova, MD
• Email: lucia.veverkova@fnol.cz
• Phone: +420603181913

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• How breast density affects mammogram screening and follow-up

  This project will test whether women aged 45–75 with dense breasts have more recalls and additional diagnostic tests after routine mammograms than women with less dense breasts.

  Recruiting Azienda Sanitaria Locale CN2 Alba-Bra · Verduno, Italy/CN · NCT07415499

• Screening mammograms with or without AI assistance for breast cancer detection

  This trial will try using an FDA-cleared AI tool to help radiologists read screening mammograms for adults to see if it finds more cancers and reduces unnecessary callbacks.

  Recruiting at 6 sites Phase 4 Jonsson Comprehensive Cancer Center · Los Angeles, California and 5 other locations · NCT06934239

• AI-assisted whole-course management for safe medicine use in advanced solid tumors

  A real-world study compares a smartphone-based digital management system with usual care to see if it reduces drug-related problems and healthcare needs for adults with advanced solid tumors receiving cancer therapy.

  Recruiting at 2 sites Tianjin Medical University Second Hospital · Tianjin, Tianjin Municipality and 1 other locations · NCT07917351

• AI-assisted and traditional workflows for admission diagnosis and management planning

  This trial tests whether an AI-agent workflow helps doctors make better admission diagnoses and care plans on simulated cases, compared with plain AI-assisted and traditional workflows.

  Recruiting Second Affiliated Hospital, Zhejiang University, School of Medicine · Hangzhou, Zhejiang · NCT07760051

• Prediction score for death or lung transplant in emphysema caused by alpha-1 antitrypsin deficiency

  This study tests a new prediction tool to identify people with emphysema due to alpha-1-antitrypsin deficiency who are at high risk of death or needing a lung transplant.

  Recruiting at 4 sites University Hospital, Bordeaux · Bron and 3 other locations · NCT07715617

• Timing of AI Help in Chest X-Rays: Does When AI Becomes Visible Change How Clinicians Read Images?

  Doctors test chest X-ray interpretation with AI information shown either before or after they start reviewing the image to see how timing affects their search patterns and decisions.

  Recruiting University Hospitals, Leicester · Leicester, Leicestershire · NCT07675694

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.